Cargando…
Osteopenia: A Diagnostic and Therapeutic Challenge
We discussed whether we are able to select a subgroup of patients with osteopenia having a high fracture risk, in which anti-osteoporotic drug treatment can be advocated. We concluded that in individuals in whom, based on clinical risk factors, a dual-energy x-ray absorptiometry (DXA) was performed...
Autores principales: | Lems, Willem F., Raterman, Hennie G., van den Bergh, Joop P. W., Bijlsma, Hans W. J., Valk, Niek K., Zillikens, M. Carola, Geusens, Piet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149119/ https://www.ncbi.nlm.nih.gov/pubmed/21695407 http://dx.doi.org/10.1007/s11914-011-0062-3 |
Ejemplares similares
-
Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide
por: Raterman, Hennie G., et al.
Publicado: (2019) -
Assessment of Individual Fracture Risk: FRAX and Beyond
por: van den Bergh, Joop P. W., et al.
Publicado: (2010) -
Calcium and vitamin D supplementation: state of the art for daily practice
por: van der Velde, Robert Y., et al.
Publicado: (2014) -
Common mechanisms and holistic care in atherosclerosis and osteoporosis
por: Szekanecz, Zoltán, et al.
Publicado: (2019) -
Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review
por: Elbers, Laura P. B., et al.
Publicado: (2021)